Normally, I would never make an outrageous claim like this

This is it  You are receiving this as a part of your subscription to The Startup Investor. To remove your email from this list, [unsubscribe here](.  [The Startup Investor] Dear Startup Investor, [This is it](... The entire world is now putting its faith and money into a [small handful]( of companies... - Companies that are developing a vaccine for COVID-19. Over $12 billion has been invested into these companies, and the race is [officially underway](. The only problem is... With 70 companies now racing to produce a [viable vaccine](... Very few people know... - WHICH of these companies is ahead of the game... - WHOSE vaccine will likely reach the market first, and... - HOW long it could take to arrive to your town. [Well, I have answers]( Ever since California issued a statewide "stay at home" order on March 19... I've reached out to every CEO, scientist, vaccinologist, and biochemist in order to find out [who is likely going to win this race](... And I can tell you that one company is [far ahead]( of everyone else. In fact, they've been testing their COVID-19 vaccine on humans since early April. Results from these trials are scheduled to drop no later than [June 30, 2020](. Once this happens, I expect the stock to go up [3,000% in record time](. In fact, the CEO is so confident in the outcome of these trials, he's already announced that the first million doses of the vaccine could be distributed for emergency use in a matter of months. In so many words... [You'd be CRAZY not to consider buying shares now](. [Situations like these]( are extremely rare. Good day, Michael Robinson Director of Technology and Venture Capital Research, Money Morning Please do not reply to this email. It was sent from an unmonitored mailbox. You are receiving this e-mail at {EMAIL}, as part of your subscription to The Startup Investor. To remove your email from this list: [unsubscribe here](. To cancel, or for any other questions or requests, please contact our Customer Service team: [Online]( Phone: 866-310-1498 (North America) 410-501-5876 (International) Mail: The Startup Investor | Attn: Member Services | 1125 N Charles Street | Baltimore, MD 21201 Our Customer Service team is available Monday ‑ Friday between 9:00 AM and 5:00 PM ET. © 2020 Angels & Entrepreneurs. All Rights Reserved. Nothing in this email should be considered personalized financial advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized financial advice. We expressly forbid our writers from having a financial interest in any security recommended to our readers. All of our employees and agents must wait 24 hours after on-line publication or 72 hours after the mailing of printed-only publication prior to following an initial recommendation. Any investments recommended in this letter should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. This Newsletter may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of: Angels & Entrepreneurs. 1125 N Charles Street, Baltimore, MD 21201. [Website]( | [Privacy Policy]( | [Terms & Conditions](